| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |